MEDICATION ADMINISTRATION POLICY THIS IS NOT A MEDICAL ORDER
|
|
- Austen Barber
- 5 years ago
- Views:
Transcription
1 ADULT PEDIATRIC APPROVAL MASMAP PMAP Approved by: PMAP November 14, 2013 Peds P&T January 20, 2014 Professional Involved: Physicians, Nurses, Pharmacists Key Words: Amiodarone, Cardiac arrest, Ventricular tachycardia, Supraventricular tachycardia Title: Amiodarone Route: IV/IO MUHC Policy #: Reserved Section Effective Date: January 20, 2014 Updated: January 28, 2015 Date for Revision: High Risk Medication: Associated practice related to medication: 1. PURPOSE (This is not a medical order) To provide a guideline for decision-making related to the administration of IV Amiodarone. This protocol does not apply to the administration of PO Amiodarone. 2. SCOPE The administration of this medication is restricted to Critical care areas (paediatric intensive care unit (PICU), Neonatal intensive care unit (NICU), and the Emergency department), where one to one monitoring and expertise are provided within the paediatric sites at the MUHC. Clinicians administering this medication are required to be PALS certified or similarly trained and familiar with this protocol prior to administration. All monitoring requirements must be adhered to and documented. 3. PROTOCOL SEE ATTACHED PROTOCOL 4. PREPRINTED ORDER FORMS / RÉGLE DE SOINS INFIRMIERS - SEE ATTACHED 5. POLICY SEE BELOW INDICATIONS As per PALS algorithm is recommended for the treatment of: Ventricular fibrillation (VF) or Ventricular tachycardia (VT) cardiac arrest Perfusing arrhythmias such as VT with pulse Supraventricular Tachycardia (SVT) Any other ventricular arrhythmias where Cardiology recommends the use of this agent (eg. Junctional ectopic tachycardia) CONTRAINDICATIONS Known hypersensitivity to Amiodarone or to any of its components, including iodine and polysorbate (Tween 80) Severe sinus node dysfunction Second or third-degree atrioventricular block Marked sinus bradycardia Severe bradycardia causing syncope Cardiogenic shock Acute hepatitis or pulmonary interstitial abnormalities Known congenital long QT syndrome Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 1 of 7
2 5.1.3 PRECAUTIONS Hepatic impairment Cardiac devices (e.g. Implantable cardioverter defibrillators, pacemakers) Concurrent therapy with drugs metabolized by CYP enzymes, and drugs with QT prolongation potential Hypo or hyperthyroidism Neonates: use with caution as Amiodarone 50 mg/ml injectable contains 20.2 mg/ml of benzyl alcohol. Benzyl alcohol (equal to or greater than 99 mg/kg/day) has been associated with gasping syndrome in neonates ADVERSE REACTIONS CVS: Bradycardia and AV blocks, cardiac arrhythmias, cardiogenic shock, hypotension CNS: Tremors, poor coordination, abnormal gait/ataxia Respiratory: Pulmonary toxicity Endocrine & metabolic: Hyperthyroidism, hypothyroidism Hematologic: Coagulation abnormalities Local: Phlebitis 5.2 PREGNANCY AND LACTATION Amiodarone and its active metabolite Cross the placenta and may cause fetal harm, leading to congenital goiter and hypo- or hyperthyroidism. Enter breast milk.. Breastfeeding is not recommended. 5.3 PHARMACOKINETICS IV: Rapid redistribution with a decrease to 10% of peak values within minutes after completion of infusion. Highly protein bound. Mainly metabolized in the liver by CYP450 cytochromes and form active metabolite (N-desethylamiodarone). Half-life for single IV dose: days; for N-desethylamiodarone (active metabolite) it is days. Half-life may be shortened in children. Elimination via biliary excretion. Amiodarone and its metabolites are NOT dialyzable. 5.4 ADMINISTRATION Prepare Amiodarone at the standard 2 mg/ml Adjust administration rate to patient s clinical condition and urgency Loading dose may be given as 1 mg/kg aliquots Maximum bolus infusion rate: 15 mg/min, does not apply in a cardiac arrest situation Administer continuous IV infusion with a volumetric pump at a rate not exceeding 0.25 mg/kg/min, unless clinically indicated A 0.2 micron in-line filter is recommended for continuous IV infusion Infusion exceeding 2 hours must be mixed in a polyolefin (non-pvc) bag Central line is the preferred route of administration to decrease risk of superficial phlebitis, however a large peripheral vein may be used if central access is not immediately available Hypokalemia or hypomagnesaemia must be corrected prior to treatment with Amiodarone IV due to the risk of torsade de pointes Refer to Table 1 and 2 for Amiodarone Dose and Administration Refer to Appendix 1 for Amiodarone infusion preparation STORAGE Store between 20 and 25 C. Protect from light and excessive heat. Discard unused portion. Diluted solutions do not require protection from light during IV administration SUPPLIES Vial 50 mg/ml (3 ml) Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 2 of 7
3 5.4.3 COMPATIBILITY Amiodarone is stable in D5W at a 1 6 mg/ml at room temperature for: 24 hours in a polyolefin (Non-PVC) bag 2 hours in a PVC bag Y-Site Compatible (non-exhaustive list): atropine, calcium chloride, calcium gluconate, EPINEPHrine, norepinephrine, potassium chloride up to 40 mmol/l, vasopressin Y-Site incompatibility (non-exhaustive list): Aminophylline, cefazolin, digoxin, heparin, magnesium sulfate, sodium bicarbonate DOSE Filter is not required Maximum infusion rate does not apply ALERT - IN CARDIAC ARREST SITUATION Table 1. Amiodarone Dose and Administration for Cardiac Arrest Neonates/Infants/Children/Adolescents Indication Dose Dilution Infusion Rate Pulseless VT/VF (Cardiac Arrest) 5 mg/kg IV/IO Maximum single dose: 300 mg IV/IO Dilute dose in a total of 20 ml D5W or NS Rapid IV/IO push by physician 15 mg/kg IV/IO up to 2.2 g/day Adults Indication Dose Dilution Infusion Rate Pulseless VT/VF (Cardiac Arrest) 300 mg IV/IO Supplemental dose: 150 mg IV, if pulseless VT or VF continues or recurs after subsequent defibrillation attempt Dilute dose in total of 20 ml D5W or NS Rapid IV/IO push by physician 2.2 g/day Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 3 of 7
4 Table 2. Amiodarone Dose and Administration for SVT, VT with Pulses Neonates/Infants/Children/ Adolescents Indication Dose Dilution Infusion Rate Ventricular Arrhythmias (VT with Pulse) and SVT with a pulse Loading dose: 5 mg/kg IV/IO Maximum single dose: 300 mg May repeat initial loading dose if no conversion 15 mg/kg or 2.2 g/day Dilute to a 2 mg/ml with D5W (empty polyolefin bag) Infuse over minutes May be given as 1 mg/kg aliquots over 5-10 minutes Maintenance infusion: Initial: 5 mcg/kg/min IV Usual range: 5-15 mcg/kg/min Maximum 15 mcg/kg/min 2.2 g/day (bolus AND infusion) Dilute 500 mg in total of 250 ml D5W for a 2 mg/ml (empty polyolefin bag) see Appendix 1 for Infusion preparation Use a 0.2 micron in-line filter * Please consult Cardiology for further dosing recommendations Adults Initial dose of 1050 mg over the first 24 hours given in a 3-phase sequence: rapid loading phase, slow loading phase, and maintenance infusion phase (see below). Indication Dose Dilution Infusion Rate Ventricular Arrhythmias (VT with Pulse) and SVT with a pulse 1. Rapid loading phase 150 mg IV 2. Slow loading phase 360 mg IV over 6 hours Dilute in 75 ml D5W (2 mg/ml) Dilute in 180 ml D5W for a 2 mg/ml (empty polyolefin bag) Infuse over 10 minutes (15 mg/min) then, Infuse at 1 mg/min (30 ml/h) for 6 hours then, Use a 0.2 micron in-line filter. 3. Maintenance infusion 540 mg IV over 18 hours * Please consult Cardiology for further dosing recommendations Dilute in 270 ml D5W for a 2 mg/ml (empty polyolefin bag) Infuse at 0.5 mg/min (15 ml/h) for 18 hours Use a 0.2 micron in-line filter. Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 4 of 7
5 5.5 MONITORING Prior to administration obtain: Baseline vital signs Correct any electrolytes imbalances in particular hypokalemia and hypomagnesaemia 12 lead ECG with a rhythm strip if the clinical condition of the patient allows it Consultation with Cardiology should be sought when considering Amiodarone if the clinical condition of the patient allows it Continuous cardiac monitoring is mandatory throughout therapy Document blood pressure, heart rate, respiratory rate, oxygen saturation, q 5 minutes x 3, q 15 minutes x 3, then q 1h or more frequently, as clinically indicated Hypotension and bradycardia during IV infusion can usually be managed by reduction of the drug infusion rate A second large bore IV access should be available for possible fluid resuscitation Observe for bradycardia, AV blocks, torsade de pointe hypotension, and clinical signs of worsening heart failure Monitoring parameters: serum electrolytes (especially potassium and magnesium), liver enzymes, ECG as per physician order (risk of prolonged QT interval), INR if interacting medications If peripheral IV Amiodarone infusion, monitor IV site q 1h for signs of phlebitis for the duration of peripheral infusion. Cardiologist consult required to monitor pacing or defibrillation thresholds in patient with implanted cardiac devices ALERT A defibrillator with the capacity of external pacing must be in proximity to the bedside during IV Amiodarone administration with appropriate patient size external pacing pads Physician in charge should be familiar in activating the pacing function of the defibrillator Physician in charge of the patient should be familiar with how to start external pacing if required Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 5 of 7
6 REFERENCES: Taketomo, C.K., Hodding, J.H., Kraus, M.D. ( ) Pediatric and Neonatal Dosage Handbook, 19th edition Lexicomp Ottawa Hospital Parenteral Drug Therapy Manual, 31 st edition Kleinman M.E., Chameides L, Schexnayder S.M et al. Pediatric Advanced Life Support:2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics,126(5): e Sandoz Canada (2005). Product Monograph: Amiodarone hydrochloride for injection. Retrieved on Aug 21, 2013 from: Perry JC., Fenrich AL, Hulse JE, et al. Pediatric use of intravenous amiodarone : efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol, 1996, 27(5): MAIN AUTHORS: Nora Ruo, B. Pharm, M.Sc, Pediatric intensive care pharmacist Denise Kudirka, Cadre conseil en soins infirmiers spécialisés urgence pédiatrique CONSULTANTS: Marie Antonacci, BSc.N. Gabrielle Girard, B. Pharm, M.Sc, Neonatal intensive care pharmacist Dr Adrian Dancea, Cardiologist Dr Samara Zavalkoff, Pediatric Intensivist Dr Dubravka Diksic, Pediatric Emergentologist Marjorie Friesen, Pharmacist at Drug information center Michel Sergerie, Cadre conseil en soins infirmiers spécialisés cardiologie Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 6 of 7
7 Appendix 1 SVT, VT with Pulses: PREPARATION of INFUSION for Neonates/Infants/Children/ Adolescents Concentration: Prepare an infusion at a 2 mg/ml Solution: Dilute 500 mg of amiodarone (10 ml) in 240 ml D5W For a final volume of 250 ml at a final 2 mg/ml (2000 mcg/ml) CALCULATION of RATE rate = dose (mcg/kg/min) X weight (kg) X 60 minutes (ml/h) (ml/h) concentration (mcg/ml) EXAMPLE: medical order : 5 mcg/kg/min for a 30 kg child rate = 5 mcg/kg/min X 30 kg X 60 minutes (ml/h) rate = 4.5 ml/h (ml/h) 2000 mcg/ml Medication Administration Policy - Pediatric Amiodarone Final Update January 28, 2015 Page 7 of 7
Objectives: This presentation will help you to:
emergency Drugs Objectives: This presentation will help you to: Five rights for medication administration Recognize different cardiac arrhythmias and determine the common drugs used for each one List the
More informationEuropean Resuscitation Council
European Resuscitation Council Objectives To know basic elements to evaluate patients with rythm disturbance To know advanced treatment of paediatric cardiac arrest To know emergency treatment of most
More informationPEDIATRIC CARDIAC RHYTHM DISTURBANCES. -Jason Haag, CCEMT-P
PEDIATRIC CARDIAC RHYTHM DISTURBANCES -Jason Haag, CCEMT-P General: CARDIAC RHYTHM DISTURBANCES - More often the result and not the cause of acute cardiovascular emergencies - Typically the end result
More informationManufacturer-prepared NEXTERONE (amiodarone HCl) Ready for you. Ready for the patient.
AT A MOMENT S NOTICE Manufacturer-prepared NEXTERONE (amiodarone HCl) Ready for you. Ready for the patient. Indications and Usage NEXTERONE (amiodarone HCl) Premixed Injection is indicated for initiation
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationAdenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT
Adenosine Indications: 1. Narrow complex PSVT 2. Does not convert atrial fibrillation, atrial flutter or VT 1. Side effects include flushing, chest pain, transient asystole 2. May deteriorate widecomplex
More informationAdvanced Resuscitation - Child
C02C Resuscitation 2017-03-23 1 up to 10 years Office of the Medical Director Advanced Resuscitation - Child Intermediate Advanced Critical From PRIMARY ASSESSMENT Known or suspected hypothermia Algorithm
More informationALS MODULE 7 Pharmacology
ALS MODULE 7 Pharmacology Relates to HLT404C Apply Advanced Resuscitation Techniques Introduction There are no studies that addressed the order of drug administration. There is inadequate evidence to define
More informationMichigan Pediatric Cardiac Protocols. Date: November 15, 2012 Page 1 of 1 TABLE OF CONTENTS
Date: November 15, 2012 Page 1 of 1 TABLE OF CONTENTS Pediatric Asystole Section 4-1 Pediatric Bradycardia Section 4-2 Pediatric Cardiac Arrest General Section 4-3 Pediatric Narrow Complex Tachycardia
More informationAdvanced Resuscitation - Adolescent
C02B Resuscitation 2017-03-23 10 up to 17 years Office of the Medical Director Advanced Resuscitation - Adolescent Intermediate Advanced Critical From PRIMARY ASSESSMENT Known or suspected hypothermia
More information50% Concentrated Injection
NAME OF THE MEDICINE. The molecular weight of the compound is 246.5 and the CAS registry number is 10034-99-8. The molecular formula is MgSO4, 7H2O. DESCRIPTION MAGNESIUM SULFATE HEPTAHYDRATE 50% CONCENTRATED
More informationAdvanced Resuscitation - Adult
C02A Resuscitation 2017-03-23 17 years & older Office of the Medical Director Advanced Resuscitation - Adult Intermediate Advanced Critical From PRIMARY ASSESSMENT Known or suspected hypothermia Algorithm
More informationDBL MAGNESIUM SULFATE CONCENTRATED INJECTION
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION NAME OF MEDICINE Magnesium Sulfate BP DESCRIPTION DBL Magnesium Sulfate Concentrated Injection is a clear, colourless, sterile solution. Each ampoule contains
More informationMichigan Pediatric Cardiac Protocols. Date: November 15, 2012 Page 1 of 1 TABLE OF CONTENTS
Date: November 15, 2012 Page 1 of 1 TABLE OF CONTENTS Pediatric Asystole Section 4-1 Pediatric Bradycardia Section 4-2 Pediatric Cardiac Arrest General Section 4-3 Pediatric Narrow Complex Tachycardia
More informationPreparing for your upcoming PALS course
IU Health PALS Study Guide Preparing for your upcoming PALS course UPDATED November 2016 Course Curriculum: 2015 American Heart Association (AHA) Guidelines for Pediatric Advanced Life Support (PALS) AHA
More informationADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments
ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest
More informationPediatric Code Blue FOCUS on Medications. Objectives
Pediatric Code Blue FOCUS on Medications Objectives The learner will be able to: 1. List commonly used pediatric code drugs based on PALS 2015 guidelines 2. Discuss mechanism of action, clinical indications,
More informationThe ARREST Trial: Amiodarone for Resuscitation After Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
The ARREST Trial: Amiodarone for Resuscitation After Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation Introduction The ARREST (Amiodarone in out-of-hospital Resuscitation of REfractory Sustained
More informationSTANDARDIZED PROCEDURE CARDIAC STRESS TESTING-EXERCISE TESTING (Adult, Peds)
I. Definition: During the exercise test, the patient exercises on a bike or treadmill while being monitored with a 12 lead ECG, blood pressure device, pulse oximetry and, if requested, oxygen consumption,
More informationMASTER SYLLABUS
A. Academic Division: Health Sciences B. Discipline: Respiratory Care MASTER SYLLABUS 2018-2019 C. Course Number and Title: RESP 2330 Advanced Life Support Procedures D. Course Coordinator: Tricia Winters,
More informationAdrenaline 1mg in 10mL (1:10,000) Pre-filled syringe 3 Amiodarone 300mg/10mL Pre-filled syringe 5
Quick Reference Guide for: Cardiac Arrest Medicines Box (BLUE) Please Note: Any medicines given must form part of an Airway, Breathing, Circulation, Disability and Exposure (ABCDE) Assessment (9)999 must
More informationANZCOR Guideline 12.4 Medications and Fluids in Paediatric Advanced Life Support
ANZCOR Guideline 12. Medications and Fluids in Paediatric Advanced Life Support Who does this guideline apply to? This guideline applies to infants and children. Summary Who is the audience for this guideline?
More informationWHAT DO YOU SEE WHEN YOU STIMULATE BETA
CARDIAC DRUG REVIEW WHAT DO YOU SEE WHEN YOU STIMULATE BETA VASODILATE BRONCHODILATE +CHRONOTROPE +INOTROPE EPI S OTHER NAME? ADRENALIN WHAT DOES EPI DO THAT NOREPI AND DOPAMINE DO NOT DO? BETA 2 BRONCHODILATOR
More informationParamedic Pediatric Medical Math Practice
Paramedic Pediatric Medical Math Practice Name: Date: Problem 1 Your 4 year old patient weighs 40 pounds. She is febrile. You need to administer acetaminophen (Tylenol) 15mg/kg. How many mg will you administer?
More informationAntiarrhythmic Drugs Öner Süzer
Antiarrhythmic Drugs Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 09.11.2009 1 Süzer Farmakoloji 3. Baskı 2005 2 1 Süzer Farmakoloji 3. Baskı 2005 3 Figure 14 1 Schematic representation
More informationEmergency Cardiovascular Care: EMT-Intermediate Treatment Algorithms. Introduction to the Algorithms
Emergency Cardiovascular Care: EMT-Intermediate Treatment Algorithms Introduction to the Algorithms Cardiac Arrest Algorithms Prehospital Medication Profiles Perspective regarding the EMT- Intermediate
More information1 Pediatric Advanced Life Support Science Update What s New for 2010? 3 CPR. 4 4 Steps of BLS Survey 5 CPR 6 CPR.
1 Pediatric Advanced Life Support Science Update 2010 2 What s New for 2010? 3 CPR Take no longer than seconds for pulse check Rate at least on per minute (instead of around 100 per minute ) Depth change:
More informationCardiac arrhythmias in the PICU
Cardiac arrhythmias in the PICU Paolo Biban, MD Director, Neonatal and Paediatric Intensive Care Unit Division of Paediatrics, Major City Hospital Azienda Ospedaliera Universitaria Integrata Verona, Italy
More informationMICHIGAN. State Protocols. Pediatric Cardiac Table of Contents 6.1 General Pediatric Cardiac Arrest 6.2 Bradycardia 6.
MICHIGAN State Protocols Protocol Number Protocol Name Pediatric Cardiac Table of Contents 6.1 General Pediatric Cardiac Arrest 6.2 Bradycardia 6.3 Tachycardia PEDIATRIC CARDIAC PEDIATRIC CARDIAC ARREST
More informationEKG Rhythm Interpretation Exam
as EKG Rhythm Interpretation Exam Name: Date: ID# Unit Assume each strip is a 6 second strip. Passing is 80%. 1. Identify the following rhythm: a. Asystole b. Ventricular fibrillation c. Atrial fibrillation
More informationRequirements to successfully complete PALS:
The American Heart Association released new resuscitation science and treatment guidelines on October 19, 2010. The new AHA Handbook of Emergency Cardiac Care (ECC) contains these 2010 Guidelines.The 2010
More informationINSTITUTE FOR MEDICAL SIMULATION & EDUCATION ACLS PRACTICAL SCENARIOS
Practical Teaching for Respiratory Arrest with a Pulse (Case 1) You are a medical officer doing a pre-operative round when 60-year old patient started coughing violently and becomes unconscious. Fortunately
More information1. Normal sinus rhythm 2. SINUS BRADYCARDIA
1. Normal sinus rhythm 2. SINUS BRADYCARDIA No signs and symptoms observe There are severe signs or symptoms o What are the signs and symptom Hypotension
More informationAdult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES
Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal
More informationPALS Case Scenario Testing Checklist Respiratory Case Scenario 1 Upper Airway Obstruction
Respiratory Case Scenario 1 Upper Airway Obstruction Directs administration of 100% oxygen or supplementary oxygen as needed to support oxygenation Identifies signs and symptoms of upper airway obstruction
More informationCORDARONE Sanofi-Aventis
CORDARONE Sanofi-Aventis Composition Amiodarone 200 mg; tablets. Also AMPOULES 150 mg/3 ml. Indications Tablets Prevention of recurrence of the following: life-threatening ventricular tachycardias in which
More informationDYSRHYTHMIAS. D. Assess whether or not it is the arrhythmia that is making the patient unstable or symptomatic
DYSRHYTHMIAS GENERAL CONSIDERATIONS A. The 2015 American Heart Association Guidelines were referred to for this protocol development. Evidence-based science was implemented in those areas where the AHA
More informationAmiodarone. Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers
Amiodarone Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Licensed Indications Tachyarrhythmias associated with Wolff-Parkinson-White syndrome All types of tachyarrhythmias
More informationDrug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension
More informationAcute Arrhythmias in the Hospitalized Patient
Acute Arrhythmias in the Hospitalized Patient Gregory M Marcus, MD, MAS Associate Professor of Medicine Division of Cardiology University of California, San Francisc Disclosures Medtronic: Research Support
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationACLS Prep. Preparation is key to a successful ACLS experience. Please complete the ACLS Pretest and Please complete this ACLS Prep.
November, 2013 ACLS Prep Preparation is key to a successful ACLS experience. Please complete the ACLS Pretest and Please complete this ACLS Prep. ACLS Prep Preparation is key to a successful ACLS experience.
More information6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center
RATE Abciximab (Reopro) Alteplase (tpa, Activase) All units 6S and 6W ONLY Platelet aggregation inhibitor Thrombolytic agent Bolus: 0.25 mg/kg IV over 5 min Infusion: 0.125 0.9 mg/kg (max 90 mg); 10% of
More informationACLS Review. Pulse Oximetry to be between 94 99% to avoid hyperoxia (high oxygen tension can lead to tissue death
ACLS Review BLS CPR BLS CPR changed in 2010. The primary change is from the ABC format to CAB. After establishing unresponsiveness and calling for a code, check for a pulse less than 10 seconds then begin
More informationPEDIATRIC SVT MANAGEMENT
PEDIATRIC SVT MANAGEMENT 1 INTRODUCTION Supraventricular tachycardia (SVT) can be defined as an abnormally rapid heart rhythm originating above the ventricles, often (but not always) with a narrow QRS
More informationRhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014
Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias
More informationUpdate of CPR AHA Guidelines
Update of CPR AHA Guidelines Donald Hal Shaffner Course objective is to have an updated understanding of the American Heart Association s treatment algorithms for the management of cardiac decompensation
More informationPRODUCT MONOGRAPH. 2% Lidocaine Hydrochloride Injection USP 20 mg/ml
PRODUCT MONOGRAPH 2% Lidocaine Hydrochloride Injection USP 20 mg/ml 0.4 % Lidocaine Hydrochloride and 5% Dextrose Injection USP Lidocaine Hydrochloride and Dextrose Injection USP Lidocaine Hydrochloride
More informationTreatment of Arrhythmias in the Emergency Setting
Treatment of Arrhythmias in the Emergency Setting Zian H. Tseng, M.D. Assistant Professor of Medicine Cardiac Electrophysiology Section Cardiology Division University of California, San Francisco There
More informationChapter 26. Media Directory. Dysrhythmias. Diagnosis/Treatment of Dysrhythmias. Frequency in Population Difficult to Predict
Chapter 26 Drugs for Dysrythmias Slide 33 Slide 35 Media Directory Propranolol Animation Amiodarone Animation Upper Saddle River, New Jersey 07458 All rights reserved. Dysrhythmias Abnormalities of electrical
More informationCSI Skills Lab #5: Arrhythmia Interpretation and Treatment
CSI 202 - Skills Lab #5: Arrhythmia Interpretation and Treatment Origins of the ACLS Approach: CSI 202 - Skills Lab 5 Notes ACLS training originated in Nebraska in the early 1970 s. Its purpose was to
More informationAntiarrhythmic Drugs Öner Süzer
Antiarrhythmic Drugs Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 13.01.2009 1 Süzer Farmakoloji 3. Baskı 2005 2 1 Süzer Farmakoloji 3. Baskı 2005 3 Figure 14 1 Schematic representation
More informationBlood pressure parameters for iv amiodarone
Blood pressure parameters for iv amiodarone Search 17-7-2012 ICU & Fluids - Electrolytes - Nutrition: Edited by Andy S. Binder, MD, Pulmonologist, Critical Care. Contents: Electrolytes : Fluids: Dehydration.
More informationDOBUTamine INJECTION, USP R x only
DOBUTamine INJECTION, USP R x only DESCRIPTION Dobutamine Injection, USP is 1,2-benzenediol, 4-[2-[[3-(4-hydro-xyphenyl)-1- methylpropyl]amino]ethyl]-hydrochloride, (±). It is a synthetic catecholamine.
More informationResuscitation Fluids
Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be
More informationMICHIGAN. State Protocols
MICHIGAN State Protocols Protocol Number 5.1 5.2 5.3 5.4 5.5 Protocol Name Adult Cardiac Table of Contents General Cardiac Arrest Bradycardia Tachycardia Pulmonary Edema/CHF Chest Pain/Acute Coronary Syndrome
More informationPrehospital Care Monograph
Prehospital Care Monograph Amiodarone (Cordarone) City of Pittsburgh Bureau of Emergency Medical Services And Medical Direction Committee Center for Emergency Medicine Of Western Pennsylvania 1 This monograph
More informationa lecture series by SWESEMJR
Electrolyte disturbances Hypokalaemia Decreased extracellular potassium increases excitability in the myocardial cells and consequently the effect of very severe hypokalaemia is ventricular arrhythmia.
More informationPHARMACOLOGY OF ARRHYTHMIAS
PHARMACOLOGY OF ARRHYTHMIAS Course: Integrated Therapeutics 1 Lecturer: Dr. E. Konorev Date: November 27, 2012 Materials on: Exam #5 Required reading: Katzung, Chapter 14 1 CARDIAC ARRHYTHMIAS Abnormalities
More informationPediatric advanced life support. Management of decreased conscious level in children. Virgi ija Žili skaitė 2017
Pediatric advanced life support. Management of decreased conscious level in children Virgi ija Žili skaitė 2017 Life threatening conditions: primary assessment, differential diagnostics and emergency care.
More informationnational CPR committee Saudi Heart Association (SHA). International Liason Commission Of Resuscitation (ILCOR)
2 It is our pleasure to present to you this work as a result of team work of the national CPR committee at the Saudi Heart Association (SHA). We adapted the 2010 guidelines as per International Liason
More informationDon t Forget the Basics
Scary Arrhythmias in the Hospital Gregory M Marcus, MD, MAS Assistant Professor of Medicine Division of Cardiology University of California, San Francisc Don t Forget the Basics 79 yo man with a history
More informationAdult Advanced Cardiovascular Life Support 2015 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
Adult Advanced Cardiovascular Life Support 2015 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care 1 DR. Alireza Abootalebi Assistant Professor Of
More informationEvidence for Lidocaine and Amiodarone in Cardiac Arrest Due to VF/Pulseless VT
Evidence for Lidocaine and Amiodarone in Cardiac Arrest Due to VF/Pulseless VT Introduction Evidence supporting the use of lidocaine and amiodarone for advanced cardiac life support was considered by international
More informationCardiac Arrhythmias & Drugs used in Advanced Life Support and Cardiac Emergencies
Cardiac Arrhythmias & Drugs used in Advanced Life Support and Cardiac Emergencies CNHE Ballarat Health Services Valid from 1 st March 2016 to 31 st June 2018 1 Supraventricular Tachycardia (SVT) An atrial
More informationPOLICY and PROCEDURE
Misericordia Community Hospital Administration of Intravenous FentaNYL During Labour POLICY and PROCEDURE Labour and Delivery Manual Original Date Revised Date Approved by: Director, Women s Health, Covenant
More informationACETYLCYSTEINE INJECTION
ACETYLCYSTEINE INJECTION 1. Name of the medicinal product Acetylcysteine 200 mg/ml Injection 2. Qualitative and quantitative composition Acetylcysteine 200mg per ml (as N-acetylcysteine) Each 10ml ampoule
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Each ml solution for injection contains phenylephrine hydrochloride corresponding to 0.1 mg phenylephrine.
1. NAME OF THE MEDICINAL PRODUCT Fenylefrin Abcur 0.05 mg/ml, solution for injection Fenylefrin Abcur 0.1 mg/ml, solution for injection SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE
More informationProfessional Development Presents. May 2016 Medication of the Month. Milrinone Drip IN2731
Med of the Month For any question regarding May 2016 Med of the Month: Milrinone Drip You may contact: Sherr Ann Arabit MSN, RN-BC, CCRN/Professional Development Department Ext 4196 Professional Development
More informationVENTRICULAR FIBRILLATION. 1. Safe scene, standard precautions. 2. Establish unresponsiveness, apnea, and pulselessness. 3. Quick look (monitor)
LUCAS COUNTY EMS SUMMARY PAGES VENTRICULAR FIBRILLATION 2. Establish unresponsiveness, apnea, and pulselessness 3. Quick look (monitor) 4. Identify rhythm 5. Provide 2 minutes CPR if unwitnessed by EMS
More informationArrhythmic Complications of MI. Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine
Arrhythmic Complications of MI Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine Objectives Brief overview -Pathophysiology of Arrhythmia ECG review of typical
More informationReview Packet EKG Competency This packet is a review of the information you will need to know for the proctored EKG competency test.
Review Packet EKG Competency 2015 This packet is a review of the information you will need to know for the proctored EKG competency test. Normal Sinus Rhythm Rhythm: Regular Ventricular Rate: 60-100 bpm
More informationThe most common. hospitalized patients. hypotension due to. filling time Rate control in ICU patients may be difficult as many drugs cause hypotension
Arrhythmias in the critically ill ICU patients: Approach for rapid recognition & management Objectives Be able to identify and manage: Atrial fibrillation with a rapid ventricular response Atrial flutter
More information1. NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3. PHARMACEUTICAL FORM 4. CLINICAL PARTICULARS 9.11
9.11 1. NAME OF THE MEDICINAL PRODUCT Amiodacore Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 3ml ampoule contains 150mg amiodarone hydrochloride. For excipients, see 6.1 3. PHARMACEUTICAL
More informationDocument 3 Summary of Data and Guidance for Medical Professionals
Document 3 Summary of Data and Guidance for Medical Professionals Anvirzel Anvirzel is a novel antitumor compound extracted from the plant Nerium oleander, which belongs to the family Apocynaceae. Anvirzel
More informationSTANDARDIZED PROCEDURE CARDIAC STRESS TESTING-DOBUTAMINE INFUSION (Adult)
I. Definition: This test is performed to evaluate for cardiac ischemia, arrhythmias, and/or response to exercise. II. Background Information A. Setting: The setting (inpatient vs outpatient) and population
More informationJohnson County Emergency Medical Services Page 23
Non-resuscitation Situations: Resuscitation should not be initiated in the following situations: Prolonged arrest as evidenced by lividity in dependent parts, rigor mortis, tissue decomposition, or generalized
More informationCardiac Electrical Therapies. By Omar AL-Rawajfah, PhD, RN
Cardiac Electrical Therapies By Omar AL-Rawajfah, PhD, RN Outlines What are cardiac electrical therapies Ablation Defibrillation Cardioversion What are the nursing considerations for each type of therapy
More informationCore Content In Urgent Care Medicine
Palpitations/Arrhythmias Ebrahim Barkoudah, MD Clinical Instructor in Internal Medicine Harvard Medical School Assistant in Internal Medicine & Pediatrics Massachusetts General Hospital MGH Chelsea Chelsea,
More informationMagnesium Sulphate - Management of Hypertensive Disorders of Pregnancy
1. Purpose Magnesium sulphate is the anticonvulsant of choice for pre-eclampsia prophylaxis and treatment. This clinical guideline outlines the indications, contraindications, administration and monitoring
More informationI have nothing to disclose.
I have nothing to disclose. Antiarrhythmic Therapy in Pregnancy Prof. Ali Oto,MD,FESC,FACC,FHRS Department of Cardiology Hacettepe University,Faculty of Medicine Ankara Arrhythmias in pregnancy An increased
More informationManagement Of Medical Emergencies. Zakaria S. Messieha, DDS
Management Of Medical Emergencies Zakaria S. Messieha, DDS Z.S. Messieha Associate Professor, Anesthesiology University Of Illinois At Chicago Necessity Of Emergency Protocol Aging patient population.
More informationAdult Basic Life Support
Adult Basic Life Support UNRESPONSIVE? Shout for help Open airway NOT BREATHING NORMALLY? Call 112* 30 chest compressions 2 rescue breaths 30 compressions *or national emergency number Fig 1.2_Adult BLS
More informationChapter 03: Sinus Mechanisms Test Bank MULTIPLE CHOICE
Instant download and all chapters Tesst Bank ECGs Made Easy 5th Edition Barbara J Aehlert https://testbanklab.com/download/tesst-bank-ecgs-made-easy-5th-edition-barbara-jaehlert/ Chapter 03: Sinus Mechanisms
More informationMichigan Adult Cardiac Protocols TABLE OF CONTENTS
Date: November 15, 2012 Page 1 of 1 TABLE OF CONTENTS Asystole Section 2-1 Bradycardia Section 2-2 Cardiac Arrest General Section 2-3 Cardiac Arrest ROSC Section 2-4 Chest Pain Acute Coronary Syndrome
More informationAmiodarone Prescribing and Monitoring: Back to the Future
Amiodarone Prescribing and Monitoring: Back to the Future Subha L. Varahan, MD, FHRS, CCDS Electrophysiologist Oklahoma Heart Hospital Oklahoma City, OK Friday, February, 8 th, 2019 Iodinated benzofuran
More informationMEDICATIONS IN PREGNANCY
MEDICATIONS IN PREGNANCY If patient presents with significant past history of drug addiction pain control should be closely monitored due to increased tolerance to narcotics. Consult Pain Specialist and
More informationManual Defibrillation. CPR AGE: 18 years LOA: Altered HR: N/A RR: N/A SBP: N/A Other: N/A
ROC AMIODARONE, LIDOCAINE OR PLACEBO FOR OUT OF HOSPITAL CARDIAC ARREST DUE TO VENTRICULAR FIBRILLATION OR TACHYCARDIA (ALPS) STUDY: MEDICAL CARDIAC ARREST MEDICAL DIRECTIVE An Advanced Care Paramedic
More informationCardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski
Cardiac arrhythmias Janusz Witowski Department of Pathophysiology Poznan University of Medical Sciences A 68-year old man presents to the emergency department late one evening complaining of increasing
More information1-Epinephrine 2-Atropine 3-Amiodarone 4-Lidocaine 5-Magnesium
١ 1-Epinephrine 2-Atropine 3-Amiodarone 4-Lidocaine 5-Magnesium ٢ When VF/pulseless VT cardiac arrest is associated with torsades de pointes, providers may administer magnesium sulfate at a dose of 1-2
More informationAdvanced Cardiac Life Support G 2010
Advanced Cardiac Life Support G 2010 Produced by the Advanced Cardiac Life Support Council of the Irish Heart Foundation March 2012 Introduction: The Arrhythmia and ACLS Councils of the Irish Heart Foundation
More informationTech Corner. ATP in the Fast VT zone
Tech Corner ATP in the Fast VT zone NOTE: PLEASE NOTE THAT THE FOLLOWING INFORMATION IS A GENERAL DESCRIPTION OF THE FUNCTION. DETAILS AND PARTICULAR CASES ARE NOT DESCRIBED IN THE ARTICLE. FOR ADDITIONAL
More informationECG Changes in Patients Treated with Mild Hypothermia after Cardio-pulmonary Resuscitation for Out-of-hospital Cardiac Arrest
ECG Changes in Patients Treated with Mild Hypothermia after Cardio-pulmonary Resuscitation for Out-of-hospital Cardiac Arrest R. Schneider, S. Zimmermann, W.G. Daniel, S. Achenbach Department of Internal
More informationAtrial Fibrillation 10/2/2018. Depolarization & ECG. Atrial Fibrillation. Hemodynamic Consequences
Depolarization & ECG Atrial Fibrillation How to make ORDER out of CHAOS Julia Shih, VMD, DACVIM (Cardiology) October 27, 2018 Depolarization & ECG Depolarization & ECG Atrial Fibrillation Hemodynamic Consequences
More informationMcHenry Western Lake County EMS System Optional CE for EMT-B, Paramedics and PHRN s Bradycardia and Treatments Optional #7 2018
McHenry Western Lake County EMS System Optional CE for EMT-B, Paramedics and PHRN s Bradycardia and Treatments Optional #7 2018 This month we will be looking at a specific ECG Rhythm and its treatments
More informationUNDERSTANDING YOUR ECG: A REVIEW
UNDERSTANDING YOUR ECG: A REVIEW Health professionals use the electrocardiograph (ECG) rhythm strip to systematically analyse the cardiac rhythm. Before the systematic process of ECG analysis is described
More informationA Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children
For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:
More informationDBL NALOXONE HYDROCHLORIDE INJECTION USP
Name of medicine Naloxone hydrochloride Data Sheet New Zealand DBL NALXNE HYDRCHLRIDE INJECTIN USP Presentation DBL Naloxone Hydrochloride Injection USP is a sterile, clear, colourless solution, free from
More informationSARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY TITLE: PHARMACEUTICALS FOR CRITICAL CARE AREAS, HEMODIALYSIS, PACU, EMERGENCY CARE CENTER, CARDIAC CARE AREAS, NEURO PROGRESSIVE CARE, AND THE MECKLER
More informationPediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview
Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by
More information